Lexaria is a Canada-based biotechnology company that develops active pharmaceutical ingredients-focused oral drug delivery systems for the healthcare industry... Read more
Lexaria is a Canada-based biotechnology company that develops active pharmaceutical ingredients-focused oral drug delivery systems for the healthcare industry... Read more
News
Apr 14, 2026
Owler
Lexaria Bioscience Corp.: Lexaria Bioscience's revenue changed from $705.92K in Aug 2025 to $542K in Feb 2026
Nov 29, 2025
Owler
Lexaria Bioscience Corp.: Lexaria Bioscience's employee count had no change from Aug 2024 to Aug 2025
Apr 15, 2025
Owler
Lexaria Bioscience Corp.: Lexaria Bioscience's revenue changed from $496.92K in Nov 2024 to $525.92K in Feb 2025
Jan 13, 2025
Owler
Lexaria Bioscience Corp.: Lexaria Bioscience's revenue changed from $464.28K in Aug 2024 to $496.92K in Nov 2024
Nov 27, 2024
Owler
Lexaria Bioscience Corp.: Lexaria Bioscience's employee count changed from 5 in Sep 2023 to 7 in Aug 2024
Apr 10, 2024
Owler
Lexaria Bioscience Corp.: Lexaria Bioscience's revenue changed from $276.01K in Nov 2023 to $386K in Feb 2024
Jan 17, 2024
Owler
Lexaria Bioscience Corp.: Lexaria Bioscience's revenue changed from $226.21K in Aug 2023 to $276.01K in Nov 2023
Dec 08, 2023
Owler
Lexaria Bioscience Corp.: Lexaria Bioscience's employee count changed from 6 in Aug 2022 to 5 in Sep 2023
Dec 07, 2023
FinanzNachrichten
Lexaria Bioscience: Lexaria Bioscience Corp.: Lexaria's Investigational New Drug Application Filing Update
Dec 05, 2023
Americanbankingnews
Lexaria Bioscience: Lexaria Bioscience Corp. (NASDAQ:LEXX) to Post FY2024 Earnings of ($0.60) Per Share, Zacks Small Cap Forecasts
